Rob Sahr on the Administration’s Aggressive Approach to Bayh-Dole Compliance
The Biden Administration recently announced a plan to leverage an old tool in a new way to try to reduce drug costs: exercising “march-in rights” under the Bayh-Dole Act for drugs that were supported by government funding. ...more